CommentaryPrognosis in acute pulmonary embolism
References (6)
- et al.
Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial
Lancet
(1960) - et al.
Altepase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular dysfunction and pulmonary perfusion
Lancet
(1993) - et al.
Echocardiography doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate
Am Heart J
(1997)
Cited by (21)
Diuretics versus volume expansion in acute submassive pulmonary embolism
2017, Archives of Cardiovascular DiseasesCitation Excerpt :We found in this study that one single bolus of 40 mg furosemide, administered without delay after diagnosis assessment, is well tolerated and is not associated with RV function worsening. When compared with careful VE, it was associated with a greater improvement in HR, BNP, troponin Ic and echocardiographical markers of RV dysfunction, which are powerful prognostic factors in acute PE [2,18–26]. Our study supports the findings of Ternacle et al. [15], who reported, in 2013, a potential benefit of a diuretic treatment in submassive PE, with significant improvement in SBP, simplified PE severity index, shock index and oxygen requirement in a retrospective study with 40 patients.
Clinical implications of right ventricular dysfunction in patients with acute symptomatic pulmonary embolism: Short- and long-term clinical outcomes
2012, Journal of Critical CareCitation Excerpt :Acute pulmonary embolism (PE) is a common and life-threatening condition [1], with 3-month mortality rates of 8% to 18.6% in Western countries [2-6] and 11% in Korea [7].
Complications of Heel Surgery
2010, Clinics in Podiatric Medicine and SurgeryCitation Excerpt :Postoperative shortness of breath, diaphoresis, and general malaise in the absence of primarily an infection alerts physicians to a pulmonary embolism until proved otherwise. In some instances, death may be the sole finding of the pulmonary embolism.29 Complex regional pain syndrome (CRPS) does not have a predilection for calcaneal surgery but it must be included in any discussion.
The Evidence-Based Diagnosis of Deep Venous Thrombosis
2009, Annals of Emergency MedicineThe potential biomarkers for thromboembolism detected by SELDI-TOF-MS
2009, Thrombosis ResearchCitation Excerpt :The incidence of DVT is about 50–67 per 100 000 [2,3]. Despite adequate thrombolytic therapy, the mortalities of AMI and DVT patients, in whom cardiogenic shock or pulmonary embolism develops, remain to be high [4–6]. For suspected DVT, venous compression ultrasonography (CUS) is currently the noninvasive imaging test.
Diagnosis of pulmonary embolism: When is imaging needed?
2003, Clinics in Chest Medicine